Cargando…

Irrational prescription and its costs in neonatal surfactant therapy: public and private hospitals of Iran in 2018

BACKGROUND: Irrational prescription and its subsequent costs are a major challenge worldwide. Health systems must provide appropriate conditions for the implementation of national and international strategies to prevent irrational prescription. The aim of the present study was to determine the irrat...

Descripción completa

Detalles Bibliográficos
Autores principales: Izadi, Reyhane, Habibolahi, Abbas, Jahanmehr, Nader, Khodakarim, Soheila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10199481/
https://www.ncbi.nlm.nih.gov/pubmed/37210481
http://dx.doi.org/10.1186/s12887-023-04045-7
_version_ 1785044942807105536
author Izadi, Reyhane
Habibolahi, Abbas
Jahanmehr, Nader
Khodakarim, Soheila
author_facet Izadi, Reyhane
Habibolahi, Abbas
Jahanmehr, Nader
Khodakarim, Soheila
author_sort Izadi, Reyhane
collection PubMed
description BACKGROUND: Irrational prescription and its subsequent costs are a major challenge worldwide. Health systems must provide appropriate conditions for the implementation of national and international strategies to prevent irrational prescription. The aim of the present study was to determine the irrational surfactant prescription among neonates with respiratory distress and the resulting direct medical costs for private and public hospitals in Iran. METHODS: This was a cross-sectional descriptive study performed retrospectively using data belonged to 846 patients. Initially, the data were extracted from the patients’ medical records and the information system of the Ministry of Health. The obtained data were then compared with the surfactant prescription guideline. Afterward, each neonatal surfactant prescription was evaluated based on the three filters listed in the guideline (including right drug, right dose, and right time). Finally, chi-square and ANOVA tests were used to investigate the inter-variable relationships. RESULTS: The results showed that 37.47% of the prescriptions were irrational and the average costs of each irrational prescription was calculated as 274.37 dollars. It was estimated that irrational prescriptions account for about 53% of the total surfactant prescription cost. Among the selected provinces, Tehran and Ahvaz had the worst and the best performance, respectively. As well, public hospitals outperformed private hospitals in terms of the in drug selection, but they underperformed them in terms of the right dose determination. CONCLUSION: The results of the present study are considered as a warning to insurance organizations, in order to reduce unnecessary costs caused by these irrational prescriptions by developing new service purchase protocols. Our suggestion is the use of educational interventions to reduce irrational prescriptions due to drug selection as well as using computer alert approaches to reduce irrational prescriptions caused by wrong dose administration.
format Online
Article
Text
id pubmed-10199481
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-101994812023-05-21 Irrational prescription and its costs in neonatal surfactant therapy: public and private hospitals of Iran in 2018 Izadi, Reyhane Habibolahi, Abbas Jahanmehr, Nader Khodakarim, Soheila BMC Pediatr Research BACKGROUND: Irrational prescription and its subsequent costs are a major challenge worldwide. Health systems must provide appropriate conditions for the implementation of national and international strategies to prevent irrational prescription. The aim of the present study was to determine the irrational surfactant prescription among neonates with respiratory distress and the resulting direct medical costs for private and public hospitals in Iran. METHODS: This was a cross-sectional descriptive study performed retrospectively using data belonged to 846 patients. Initially, the data were extracted from the patients’ medical records and the information system of the Ministry of Health. The obtained data were then compared with the surfactant prescription guideline. Afterward, each neonatal surfactant prescription was evaluated based on the three filters listed in the guideline (including right drug, right dose, and right time). Finally, chi-square and ANOVA tests were used to investigate the inter-variable relationships. RESULTS: The results showed that 37.47% of the prescriptions were irrational and the average costs of each irrational prescription was calculated as 274.37 dollars. It was estimated that irrational prescriptions account for about 53% of the total surfactant prescription cost. Among the selected provinces, Tehran and Ahvaz had the worst and the best performance, respectively. As well, public hospitals outperformed private hospitals in terms of the in drug selection, but they underperformed them in terms of the right dose determination. CONCLUSION: The results of the present study are considered as a warning to insurance organizations, in order to reduce unnecessary costs caused by these irrational prescriptions by developing new service purchase protocols. Our suggestion is the use of educational interventions to reduce irrational prescriptions due to drug selection as well as using computer alert approaches to reduce irrational prescriptions caused by wrong dose administration. BioMed Central 2023-05-20 /pmc/articles/PMC10199481/ /pubmed/37210481 http://dx.doi.org/10.1186/s12887-023-04045-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Izadi, Reyhane
Habibolahi, Abbas
Jahanmehr, Nader
Khodakarim, Soheila
Irrational prescription and its costs in neonatal surfactant therapy: public and private hospitals of Iran in 2018
title Irrational prescription and its costs in neonatal surfactant therapy: public and private hospitals of Iran in 2018
title_full Irrational prescription and its costs in neonatal surfactant therapy: public and private hospitals of Iran in 2018
title_fullStr Irrational prescription and its costs in neonatal surfactant therapy: public and private hospitals of Iran in 2018
title_full_unstemmed Irrational prescription and its costs in neonatal surfactant therapy: public and private hospitals of Iran in 2018
title_short Irrational prescription and its costs in neonatal surfactant therapy: public and private hospitals of Iran in 2018
title_sort irrational prescription and its costs in neonatal surfactant therapy: public and private hospitals of iran in 2018
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10199481/
https://www.ncbi.nlm.nih.gov/pubmed/37210481
http://dx.doi.org/10.1186/s12887-023-04045-7
work_keys_str_mv AT izadireyhane irrationalprescriptionanditscostsinneonatalsurfactanttherapypublicandprivatehospitalsofiranin2018
AT habibolahiabbas irrationalprescriptionanditscostsinneonatalsurfactanttherapypublicandprivatehospitalsofiranin2018
AT jahanmehrnader irrationalprescriptionanditscostsinneonatalsurfactanttherapypublicandprivatehospitalsofiranin2018
AT khodakarimsoheila irrationalprescriptionanditscostsinneonatalsurfactanttherapypublicandprivatehospitalsofiranin2018